BBAI partnership news: how to analyze customs AI deals fast
A practical research workflow for verifying headlines, mapping revenue impact, and monitoring follow-on filings in Alpha Analyst
Blog
How Alpha Analyst is redefining investment research. Insights, team perspectives, and the latest on building AI for finance.
Latest
Company Research
NTLA US
NTLA stock jump: what the FDA clinical hold lift means
A practical explainer of Intellia’s MAGNITUDE-2 update, the key risks to track next, and how to monitor trial and regulatory signals in Alpha Analyst
Company Research
TSLA US
Tesla brand value drop in 2025: What it signals for investors
How to turn a headline about brand perception into a repeatable monitoring workflow
Company Research
MNKD US
MNKD stock jump explained: Afrezza label update and what to watch next
A practical catalyst breakdown for MannKind investors, plus a workflow to track FDA-driven moves in Alpha Analyst
Company Research
IBRX US
IBRX Volatility: How to Read “Median OS Not Reached” Updates
A biotech catalyst checklist using ImmunityBio’s glioblastoma Phase 2 headline as a case study
